UNDERWRITING AGREEMENT SEATTLE GENETICS, INC. 11,707,318 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • September 11th, 2015 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
Seattle Genetics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 11,707,318 shares of common stock, par value $ 0.001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,756,097 shares of Common Stock of the Company solely to cover over-allotments (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 11th, 2015 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”) is made as of September 10, 2015, by and between Seattle Genetics, Inc., a Delaware corporation (the “Company”), and the persons listed on the attached Schedule A who are signatories to this Agreement (collectively, the “Investors”). Unless otherwise defined herein, capitalized terms used in this Agreement have the respective meanings ascribed to them in Section 1.
